You are here
- Home
Total number of clinical trials
-
collapse
A RANDOMISED, MULTICENTRE, PHASE II, PARALLEL-GROUP TRIAL OF VANDETANIB MONOTHERAPY OR VANDETANIB IN COMBINATION WITH GEMCITABINE VERSUS GEMCITABINE PLUS VANDETANIB MATCHING PLACEBO IN SUBJECTS WITH ADVANCED BILIARY TRACT CANCER (GALLBLADDER CANCER, CANCER OF THE EXTRAHEPATIC BILE DUCT, INTRAHEPATIC
-
collapse
An Open Label Prostate Cancer Study in Japanese Patients
-
collapse
A Pharmacoepidemiological study in patients who use Symbicort Turbuhaler as maintenance and reliever therapy capturing over-use and under-use via the General Practice Research Database.
-
collapse
Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Postmenopausal Women With Advanced Breast Cancer
-
collapse
A randomised single centre phase I study to investigate the safety, tolerability and pharmacokinetics of oral multiple ascending daily doses of AZD1236 tablet by a single-blind, placebo-controlled, and single dose relative bioavailability of the oral suspension and oral tablet formulations by an open cross-over in healthy Japanese men
-
collapse
A Randomised Double-blind Phase IIa Study (With Combination Safety Run-in) to Assess the Safety and Efficacy of AZD4547 in Combination With Exemestane vs. Exemestane Alone in ER+ Breast Cancer Patients With FGFR1 Polysomy or Gene Amplification Who Have Progressed Following Treatment With One Prior Endocrine Therapy (Adjuvant or First-line Metastatic)
-
collapse
A Phase I, open label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the mTor Kinase Inhibitor AZD2014 administered orally to patients with advanced solid malignancies.
-
collapse
A phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD5423 after Administration of Single and Multiple Ascending Doses in Healthy Male Japanese Subjects
-
collapse
QUALITY OF LIFE ANALYSIS OF PROSTATE CANCER PATIENT'S TREATMENT
-
expand
Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA
- Study Id
- NIS-MENA-SA-IRS-2010/01
- Drug Name
- non drug study (oncology)
- Study Name
- NIS-MENA-SA-IRS-2010/01
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
